{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:49:32Z","timestamp":1793047772066,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41380-026-03447-0","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:58:50Z","timestamp":1770141530000},"page":"3295-3307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0959-2837","authenticated-orcid":false,"given":"Pablo","family":"Mallaroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Parker","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-0389","authenticated-orcid":false,"given":"Natasha L.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7072-9399","authenticated-orcid":false,"given":"Theodore D.","family":"Satterthwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-376X","authenticated-orcid":false,"given":"Johannes G.","family":"Ramaekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"3447_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","volume":"28","author":"RE Daws","year":"2022","unstructured":"Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, et al. Increased global integration in the brain after psilocybin therapy for depression. Nat Med. 2022;28:844\u201351.","journal-title":"Nat Med"},{"key":"3447_CR2","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s44220-024-00298-y","volume":"2","author":"G Deco","year":"2024","unstructured":"Deco G, Sanz Perl Y, Johnson S, Bourke N, Carhart-Harris RL, Kringelbach ML. Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression. Nat Ment Health. 2024;2:1096\u2013110.","journal-title":"Nat Ment Health"},{"key":"3447_CR3","doi-asserted-by":"publisher","first-page":"105421","DOI":"10.1016\/j.neubiorev.2023.105421","volume":"154","author":"S Linguiti","year":"2023","unstructured":"Linguiti S, Vogel JW, Sydnor VJ, Pines A, Wellman N, Basbaum A, et al. Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results. Neurosci Biobehav Rev. 2023;154:105421.","journal-title":"Neurosci Biobehav Rev"},{"key":"3447_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.tics.2023.01.003","volume":"27","author":"M Girn","year":"2023","unstructured":"Girn M, Rosas FE, Daws RE, Gallen CL, Gazzaley A, Carhart-Harris RL. A complex systems perspective on psychedelic brain action. Trends Cogn Sci. 2023;27:433\u201345.","journal-title":"Trends Cogn Sci"},{"key":"3447_CR5","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","volume":"25","author":"AC Kwan","year":"2022","unstructured":"Kwan AC, Olson DE, Preller KH, Roth BL. The neural basis of psychedelic action. Nat Neurosci. 2022;25:1407\u201319.","journal-title":"Nat Neurosci"},{"key":"3447_CR6","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1038\/s41380-023-02271-0","volume":"28","author":"MB Wall","year":"2023","unstructured":"Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D. Neuroimaging in psychedelic drug development: past, present, and future. Mol Psychiatry. 2023;28:3573\u201380.","journal-title":"Mol Psychiatry"},{"key":"3447_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","volume":"21","author":"TD McClure-Begley","year":"2022","unstructured":"McClure-Begley TD, Roth BL. The promises and perils of psychedelic pharmacology for psychiatry. Nat Rev Drug Discov. 2022;21:463\u201373.","journal-title":"Nat Rev Drug Discov"},{"key":"3447_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nsa.2024.103938","volume":"3","author":"D E-Wen McCulloch","year":"2024","unstructured":"E-Wen McCulloch D, Liechti ME, Kuypers KPC, Nutt D, Lundberg J, Stenb\u00e6k DS, et al. Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects. Neurosci Appl. 2024;3:103938.","journal-title":"Neurosci Appl"},{"key":"3447_CR9","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s00213-022-06142-4","volume":"239","author":"P Mallaroni","year":"2022","unstructured":"Mallaroni P, Mason NL, Vinckenbosch FRJ, Ramaekers JG. The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides. Psychopharmacology (Berl). 2022;239:1783\u201396.","journal-title":"Psychopharmacology (Berl)"},{"key":"3447_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/2050324515578080","volume":"2","author":"B Sessa","year":"2015","unstructured":"Sessa B, Fischer FM. Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary. Drug Sci Policy Law. 2015;2:2050324515578080.","journal-title":"Drug Sci Policy Law"},{"key":"3447_CR11","first-page":"1048","volume":"9","author":"MK Doss","year":"2024","unstructured":"Doss MK, Mallaroni P, Mason NL, Ramaekers JG. Psilocybin and 2C-B at encoding distort episodic familiarity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024;9:1048\u201357.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3447_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/cpt.2958","volume":"114","author":"P Mallaroni","year":"2023","unstructured":"Mallaroni P, Mason NL, Reckweg JT, Paci R, Ritscher S, Toennes SW, et al. Assessment of the acute effects of 2C-B vs. psilocybin on subjective experience, mood, and cognition. Clin Pharmacol Ther. 2023;114:423\u201333.","journal-title":"Clin Pharmacol Ther"},{"key":"3447_CR13","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1021\/acschemneuro.0c00129","volume":"11","author":"E Marcher-R\u00f8rsted","year":"2020","unstructured":"Marcher-R\u00f8rsted E, Halberstadt AL, Klein AK, Chatha M, Jademyr S, Jensen AA, Kristensen JL. Investigation of the 2, 5-dimethoxy motif in phenethylamine serotonin 2A receptor agonists. ACS Chem Neurosci. 2020;11:1238\u201344.","journal-title":"ACS Chem Neurosci"},{"key":"3447_CR14","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","volume":"26","author":"A Rickli","year":"2016","unstructured":"Rickli A, Moning OD, Hoener MC, Liechti ME. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. Eur Neuropsychopharmacol. 2016;26:1327\u201337.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3447_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.neuropharm.2015.08.034","volume":"99","author":"A Rickli","year":"2015","unstructured":"Rickli A, Luethi D, Reinisch J, Buchy D, Hoener MC, Liechti ME. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology. 2015;99:546\u201353.","journal-title":"Neuropharmacology"},{"key":"3447_CR16","doi-asserted-by":"publisher","first-page":"e9019","DOI":"10.1371\/journal.pone.0009019","volume":"5","author":"TS Ray","year":"2010","unstructured":"Ray TS. Psychedelics and the human receptorome. PLoS ONE. 2010;5:e9019.","journal-title":"PLoS ONE"},{"key":"3447_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tiv.2017.05.010","volume":"45","author":"A Zwartsen","year":"2017","unstructured":"Zwartsen A, Verboven AHA, van Kleef RGDM, Wijnolts FMJ, Westerink RHS, Hondebrink L. Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay. Toxicol In Vitro. 2017;45:60\u201371.","journal-title":"Toxicol In Vitro"},{"key":"3447_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","volume":"22","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Baumann C, Gamma A, Vollenweider FX. Acute psychological effects of 3,4-Methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology. 2000;22:513\u201321.","journal-title":"Neuropsychopharmacology"},{"key":"3447_CR19","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/cpt.2487","volume":"111","author":"AM Becker","year":"2022","unstructured":"Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, et al. Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects. Clin Pharmacol Ther. 2022;111:886\u201395.","journal-title":"Clin Pharmacol Ther"},{"key":"3447_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.neuro.051508.135535","volume":"32","author":"TW Robbins","year":"2009","unstructured":"Robbins TW, Arnsten A. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci. 2009;32:267\u201387.","journal-title":"Annu Rev Neurosci"},{"key":"3447_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fncir.2017.00108","volume":"11","author":"MC Avery","year":"2017","unstructured":"Avery MC, Krichmar JL. Neuromodulatory systems and their interactions: a review of models, theories, and experiments. Front Neural Circuits. 2017;11:108.","journal-title":"Front Neural Circuits"},{"key":"3447_CR22","doi-asserted-by":"publisher","first-page":"e31130","DOI":"10.7554\/eLife.31130","volume":"7","author":"JM Shine","year":"2018","unstructured":"Shine JM, Aburn MJ, Breakspear M, Poldrack RA. The modulation of neural gain facilitates a transition between functional segregation and integration in the brain. eLife. 2018;7:e31130.","journal-title":"eLife"},{"key":"3447_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41593-018-0312-0","volume":"22","author":"JM Shine","year":"2019","unstructured":"Shine JM, Breakspear M, Bell PT, Ehgoetz Martens KA, Shine R, Koyejo O, et al. Human cognition involves the dynamic integration of neural activity and neuromodulatory systems. Nat Neurosci. 2019;22:289\u201396.","journal-title":"Nat Neurosci"},{"key":"3447_CR24","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1016\/j.cub.2018.07.083","volume":"28","author":"G Deco","year":"2018","unstructured":"Deco G, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris RL, Whybrow PC, et al. Whole-Brain multimodal neuroimaging model using serotonin receptor maps explains non-linear functional effects of LSD. Curr Biol. 2018;28:3065\u201374.e6.","journal-title":"Curr Biol"},{"key":"3447_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33578-1","volume":"13","author":"SP Singleton","year":"2022","unstructured":"Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, et al. Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain\u2019s control energy landscape. Nat Commun. 2022;13:5812.","journal-title":"Nat Commun"},{"key":"3447_CR26","doi-asserted-by":"crossref","unstructured":"Singleton SP, Timmermann C, Luppi AI, Eckern\u00e4s E, Roseman L, Carhart-Harris RL, et al. Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience. Commun Biol. 2025;8:631.","DOI":"10.1038\/s42003-025-08078-9"},{"key":"3447_CR27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.euroneuro.2016.01.005","volume":"26","author":"T Pokorny","year":"2016","unstructured":"Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX. Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A\/2A agonist ergotamine on psilocybin-induced psychedelic experience. Eur Neuropsychopharmacol. 2016;26:756\u201366.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3447_CR28","doi-asserted-by":"publisher","first-page":"eabl6989","DOI":"10.1126\/sciadv.abl6989","volume":"8","author":"G Ballentine","year":"2022","unstructured":"Ballentine G, Friedman SF, Bzdok D. Trips and neurotransmitters: Discovering principled patterns across 6850 hallucinogenic experiences. Sci Adv. 2022;8:eabl6989.","journal-title":"Sci Adv"},{"key":"3447_CR29","doi-asserted-by":"publisher","first-page":"eadf8332","DOI":"10.1126\/sciadv.adf8332","volume":"9","author":"AI Luppi","year":"2023","unstructured":"Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, et al. In vivo mapping of pharmacologically induced functional reorganization onto the human brain\u2019s neurotransmitter landscape. Sci Adv. 2023;9:eadf8332.","journal-title":"Sci Adv"},{"key":"3447_CR30","doi-asserted-by":"publisher","first-page":"104689","DOI":"10.1016\/j.neubiorev.2022.104689","volume":"138","author":"DEW McCulloch","year":"2022","unstructured":"McCulloch DEW, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, et al. Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses. Neurosci Biobehav Rev. 2022;138:104689.","journal-title":"Neurosci Biobehav Rev"},{"key":"3447_CR31","doi-asserted-by":"crossref","unstructured":"McCulloch DE-W, Olsen AS, Ozenne B, Stenb\u00e6k DS, Armand S, Madsen MK, et al. Navigating the chaos of psychedelic neuroimaging: A multi-metric evaluation of acute psilocybin effects on brain entropy. medRxiv :2023.07.03.23292164 [Preprint]. 2023 https:\/\/www.medrxiv.org\/content\/10.1101\/2023.07.03.23292164v2.","DOI":"10.1101\/2023.07.03.23292164"},{"key":"3447_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fnhum.2013.00446","volume":"7","author":"BA Diaz","year":"2013","unstructured":"Diaz BA, Van Der Sluis S, Moens S, Benjamins JS, Migliorati F, Stoffers D, et al. The Amsterdam Resting-State Questionnaire reveals multiple phenotypes of resting-state cognition. Front Hum Neurosci. 2013;7:446.","journal-title":"Front Hum Neurosci"},{"key":"3447_CR33","doi-asserted-by":"publisher","first-page":"e12412","DOI":"10.1371\/journal.pone.0012412","volume":"5","author":"E Studerus","year":"2010","unstructured":"Studerus E, Gamma A, Vollenweider FX. Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS ONE. 2010;5:e12412.","journal-title":"PLoS ONE"},{"key":"3447_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fnhum.2016.00269","volume":"10","author":"MM Nour","year":"2016","unstructured":"Nour MM, Evans L, Nutt D, Carhart-Harris RL. Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI). Front Hum Neurosci. 2016;10:269.","journal-title":"Front Hum Neurosci"},{"key":"3447_CR35","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1152\/jn.00651.2012","volume":"109","author":"BJ Shannon","year":"2013","unstructured":"Shannon BJ, Dosenbach RA, Su Y, Vlassenko AG, Larson-Prior LJ, Nolan TS, et al. Morning-evening variation in human brain metabolism and memory circuits. J Neurophysiol. 2013;109:1444\u201356.","journal-title":"J Neurophysiol"},{"key":"3447_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41592-018-0235-4","volume":"16","author":"O Esteban","year":"2019","unstructured":"Esteban O, Markiewicz CJ, Blair RW, Moodie CA, Isik AI, Erramuzpe A, et al. fMRIPrep: a robust preprocessing pipeline for functional MRI. Nat Methods. 2019;16:111\u20136.","journal-title":"Nat Methods"},{"key":"3447_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/brain.2012.0073","volume":"2","author":"S Whitfield-Gabrieli","year":"2012","unstructured":"Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125\u201341.","journal-title":"Brain Connect"},{"key":"3447_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neuroimage.2007.04.042","volume":"37","author":"Y Behzadi","year":"2007","unstructured":"Behzadi Y, Restom K, Liau J, Liu TT. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage. 2007;37:90\u2013101.","journal-title":"Neuroimage"},{"key":"3447_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neuroimage.2016.11.052","volume":"154","author":"K Murphy","year":"2017","unstructured":"Murphy K, Fox MD. Towards a consensus regarding global signal regression for resting state functional connectivity MRI. Neuroimage. 2017;154:169\u201373.","journal-title":"Neuroimage"},{"key":"3447_CR40","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1093\/cercor\/bhx179","volume":"28","author":"A Schaefer","year":"2018","unstructured":"Schaefer A, Kong R, Gordon EM, Laumann TO, Zuo XN, Holmes AJ, et al. Local-Global parcellation of the human cerebral cortex from intrinsic functional connectivity MRI. Cereb Cortex. 2018;28:3095\u2013114.","journal-title":"Cereb Cortex"},{"key":"3447_CR41","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41593-020-00711-6","volume":"23","author":"Y Tian","year":"2020","unstructured":"Tian Y, Margulies DS, Breakspear M, Zalesky A. Topographic organization of the human subcortex unveiled with functional connectivity gradients. Nat Neurosci. 2020;23:1421\u201332.","journal-title":"Nat Neurosci"},{"key":"3447_CR42","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1152\/jn.00338.2011","volume":"106","author":"BT Yeo","year":"2011","unstructured":"Yeo BT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106:1125\u201365.","journal-title":"J Neurophysiol"},{"key":"3447_CR43","doi-asserted-by":"publisher","first-page":"e2218949120","DOI":"10.1073\/pnas.2218949120","volume":"120","author":"C Timmermann","year":"2023","unstructured":"Timmermann C, Roseman L, Haridas S, Rosas FE, Luan L, Kettner H, et al. Human brain effects of DMT assessed via EEG-fMRI. Proc Natl Acad Sci. 2023;120:e2218949120.","journal-title":"Proc Natl Acad Sci"},{"key":"3447_CR44","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/s41380-024-02734-y","volume":"30","author":"M Avram","year":"2024","unstructured":"Avram M, Fortea L, Wollner L, Coenen R, Korda A, Rogg H, et al. Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine. Mol Psychiatry. 2024;30:1297\u2013307.","journal-title":"Mol Psychiatry"},{"key":"3447_CR45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.neuroimage.2014.06.052","volume":"101","author":"MA Lindquist","year":"2014","unstructured":"Lindquist MA, Xu Y, Nebel MB, Caffo BS. Evaluating dynamic bivariate correlations in resting-state fMRI: a comparison study and a new approach. Neuroimage. 2014;101:531\u201346.","journal-title":"Neuroimage"},{"key":"3447_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuroimage.2017.07.005","volume":"158","author":"AS Choe","year":"2017","unstructured":"Choe AS, Nebel MB, Barber AD, Cohen JR, Xu Y, Pekar JJ, et al. Comparing test-retest reliability of dynamic functional connectivity methods. Neuroimage. 2017;158:155\u201375.","journal-title":"Neuroimage"},{"key":"3447_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01706-y","volume":"11","author":"MK Doss","year":"2021","unstructured":"Doss MK, Pova\u017ean M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, et al. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Transl Psychiatry. 2021;11:574.","journal-title":"Transl Psychiatry"},{"key":"3447_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73216-8","volume":"10","author":"MK Doss","year":"2020","unstructured":"Doss MK, May DG, Johnson MW, Clifton JM, Hedrick SL, Prisinzano TE, et al. The acute effects of the atypical dissociative hallucinogen salvinorin a on functional connectivity in the human brain. Sci Rep. 2020;10:16392.","journal-title":"Sci Rep"},{"key":"3447_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59282-y","volume":"10","author":"FS Barrett","year":"2020","unstructured":"Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR. Emotions and brain function are altered up to one month after a single high dose of psilocybin. Sci Rep. 2020;10:2214.","journal-title":"Sci Rep"},{"key":"3447_CR50","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/e21060541","volume":"21","author":"A Delgado-Bonal","year":"2019","unstructured":"Delgado-Bonal A, Marshak A. Approximate entropy and sample entropy: A comprehensive tutorial. Entropy. 2019;21:541.","journal-title":"Entropy"},{"key":"3447_CR51","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1021\/ar500233s","volume":"47","author":"GC Van de Bittner","year":"2014","unstructured":"Van de Bittner GC, Ricq EL, Hooker JM. A philosophy for CNS radiotracer design. Acc Chem Res. 2014;47:3127\u201334.","journal-title":"Acc Chem Res"},{"key":"3447_CR52","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41593-022-01186-3","volume":"25","author":"JY Hansen","year":"2022","unstructured":"Hansen JY, Shafiei G, Markello RD, Smart K, Cox SML, N\u00f8rgaard M, et al. Mapping neurotransmitter systems to the structural and functional organization of the human neocortex. Nat Neurosci. 2022;25:1569\u201381.","journal-title":"Nat Neurosci"},{"key":"3447_CR53","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/2041-210X.12407","volume":"6","author":"HH Wagner","year":"2015","unstructured":"Wagner HH, Dray S. Generating spatially constrained null models for irregularly spaced data using Moran spectral randomization methods. Methods Ecol Evol. 2015;6:1169\u201378.","journal-title":"Methods Ecol Evol"},{"key":"3447_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118052","volume":"236","author":"RD Markello","year":"2021","unstructured":"Markello RD, Misic B. Comparing spatial null models for brain maps. Neuroimage. 2021;236:118052.","journal-title":"Neuroimage"},{"key":"3447_CR55","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41583-023-00752-3","volume":"24","author":"V Bazinet","year":"2023","unstructured":"Bazinet V, Hansen JY, Misic B. Towards a biologically annotated brain connectome. Nat Rev Neurosci. 2023;24:747\u201360.","journal-title":"Nat Rev Neurosci"},{"key":"3447_CR56","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62116","volume":"9","author":"G Shafiei","year":"2020","unstructured":"Shafiei G, Markello RD, Vos de Wael R, Bernhardt BC, Fulcher BD, Misic B. Topographic gradients of intrinsic dynamics across neocortex. eLife. 2020;9:e62116.","journal-title":"eLife"},{"key":"3447_CR57","doi-asserted-by":"publisher","first-page":"S250","DOI":"10.1016\/j.neuroimage.2004.07.020","volume":"23","author":"AR McIntosh","year":"2004","unstructured":"McIntosh AR, Lobaugh NJ. Partial least squares analysis of neuroimaging data: applications and advances. Neuroimage. 2004;23:S250\u201363. Suppl 1","journal-title":"Neuroimage"},{"key":"3447_CR58","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.neuroimage.2010.06.041","volume":"53","author":"A Zalesky","year":"2010","unstructured":"Zalesky A, Fornito A, Bullmore ET. Network-based statistic: identifying differences in brain networks. Neuroimage. 2010;53:1197\u2013207.","journal-title":"Neuroimage"},{"key":"3447_CR59","doi-asserted-by":"publisher","first-page":"12574","DOI":"10.1073\/pnas.1608282113","volume":"113","author":"DS Margulies","year":"2016","unstructured":"Margulies DS, Ghosh SS, Goulas A, Falkiewicz M, Huntenburg JM, Langs G, et al. Situating the default-mode network along a principal gradient of macroscale cortical organization. Proc Natl Acad Sci. 2016;113:12574\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"3447_CR60","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/j.neuron.2021.06.016","volume":"109","author":"VJ Sydnor","year":"2021","unstructured":"Sydnor VJ, Larsen B, Bassett DS, Alexander-Bloch A, Fair DA, Liston C, et al. Neurodevelopment of the association cortices: Patterns, mechanisms, and implications for psychopathology. Neuron. 2021;109:2820\u201346.","journal-title":"Neuron"},{"key":"3447_CR61","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1073\/pnas.1518377113","volume":"113","author":"RL Carhart-Harris","year":"2016","unstructured":"Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci USA. 2016;113:4853\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3447_CR62","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","volume":"44","author":"MK Madsen","year":"2019","unstructured":"Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenb\u00e6k DS, Kristiansen S, et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology. 2019;44:1328\u201334.","journal-title":"Neuropsychopharmacology"},{"key":"3447_CR63","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","volume":"45","author":"NL Mason","year":"2020","unstructured":"Mason NL, Kuypers KPC, M\u00fcller F, Reckweg J, Tse DHY, Toennes SW, et al. Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. Neuropsychopharmacology. 2020;45:2003\u201311.","journal-title":"Neuropsychopharmacology"},{"key":"3447_CR64","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41386-020-00906-2","volume":"46","author":"F M\u00fcller","year":"2021","unstructured":"M\u00fcller F, Holze F, Dolder P, Ley L, Vizeli P, Soltermann A, et al. MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens. Neuropsychopharmacology. 2021;46:545\u201353.","journal-title":"Neuropsychopharmacology"},{"key":"3447_CR65","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","volume":"632","author":"JS Siegel","year":"2024","unstructured":"Siegel JS, Subramanian S, Perry D, Kay BP, Gordon EM, Laumann TO, et al. Psilocybin desynchronizes the human brain. Nature. 2024;632:131\u20138.","journal-title":"Nature"},{"key":"3447_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2022.119716","volume":"264","author":"AS Olsen","year":"2022","unstructured":"Olsen AS, Lykkebo-Vall\u00f8e A, Ozenne B, Madsen MK, Stenb\u00e6k DS, Armand S, et al. Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects. Neuroimage. 2022;264:119716.","journal-title":"Neuroimage"},{"key":"3447_CR67","doi-asserted-by":"publisher","first-page":"119220","DOI":"10.1016\/j.neuroimage.2022.119220","volume":"256","author":"M Girn","year":"2022","unstructured":"Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Nathan Spreng R. Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex. Neuroimage. 2022;256:119220.","journal-title":"Neuroimage"},{"key":"3447_CR68","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnhum.2014.00204","volume":"8","author":"L Roseman","year":"2014","unstructured":"Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL. The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers. Front Hum Neurosci. 2014;8:204.","journal-title":"Front Hum Neurosci"},{"key":"3447_CR69","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41583-023-00701-0","volume":"24","author":"JM Shine","year":"2023","unstructured":"Shine JM, Lewis LD, Garrett DD, Hwang K. The impact of the human thalamus on brain-wide information processing. Nat Rev Neurosci. 2023;24:416\u201330.","journal-title":"Nat Rev Neurosci"},{"key":"3447_CR70","doi-asserted-by":"publisher","first-page":"12295","DOI":"10.1073\/pnas.1804876115","volume":"115","author":"JM Kernbach","year":"2018","unstructured":"Kernbach JM, Yeo BTT, Smallwood J, Margulies DS, Thiebaut de Schotten M, Walter H, et al. Subspecialization within default mode nodes characterized in 10,000 UK Biobank participants. Proc Natl Acad Sci. 2018;115:12295\u2013300.","journal-title":"Proc Natl Acad Sci"},{"key":"3447_CR71","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/j.cub.2014.08.024","volume":"24","author":"A Schaefer","year":"2014","unstructured":"Schaefer A, Burmann I, Regenthal R, Ar\u00e9lin K, Barth C, Pampel A, et al. Serotonergic modulation of intrinsic functional connectivity. Curr Biol. 2014;24:2314\u20138.","journal-title":"Curr Biol"},{"key":"3447_CR72","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","volume":"26","author":"E Tagliazucchi","year":"2016","unstructured":"Tagliazucchi E, Roseman L, Kaelen M, Orban C, Muthukumaraswamy SD, Murphy K, et al. Increased global functional connectivity correlates with LSD-Induced ego dissolution. Curr Biol. 2016;26:1043\u201350.","journal-title":"Curr Biol"},{"key":"3447_CR73","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.biopsych.2019.12.027","volume":"88","author":"KH Preller","year":"2020","unstructured":"Preller KH, Duerler P, Burt JB, Ji JL, Adkinson B, St\u00e4mpfli P, et al. Psilocybin induces time-dependent changes in global functional connectivity. Biol Psychiatry. 2020;88:197\u2013207.","journal-title":"Biol Psychiatry"},{"key":"3447_CR74","doi-asserted-by":"publisher","first-page":"e35082","DOI":"10.7554\/eLife.35082","volume":"7","author":"KH Preller","year":"2018","unstructured":"Preller KH, Burt JB, Ji JL, Schleifer CH, Adkinson BD, St\u00e4mpfli P, et al. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. eLife. 2018;7:e35082.","journal-title":"eLife"},{"key":"3447_CR75","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuroimage.2019.05.060","volume":"199","author":"L-D Lord","year":"2019","unstructured":"Lord L-D, Expert P, Atasoy S, Roseman L, Rapuano K, Lambiotte R, et al. Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin. Neuroimage. 2019;199:127\u201342.","journal-title":"Neuroimage"},{"key":"3447_CR76","first-page":"681","volume":"9","author":"S Mortaheb","year":"2024","unstructured":"Mortaheb S, Fort LD, Mason NL, Mallaroni P, Ramaekers JG, Demertzi A. Dynamic functional hyperconnectivity after psilocybin intake is primarily associated with oceanic boundlessness. Biol Psychiatry: Cogn Neurosci Neuroimaging. 2024;9:681\u201392.","journal-title":"Biol Psychiatry: Cogn Neurosci Neuroimaging"},{"key":"3447_CR77","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/pr.118.017160","volume":"71","author":"RL Carhart-Harris","year":"2019","unstructured":"Carhart-Harris RL, Friston KJ. REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacol Rev. 2019;71:316\u201344.","journal-title":"Pharmacol Rev"},{"key":"3447_CR78","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41583-020-0367-2","volume":"21","author":"FX Vollenweider","year":"2020","unstructured":"Vollenweider FX, Preller KH. Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. Nat Rev Neurosci. 2020;21:611\u201324.","journal-title":"Nat Rev Neurosci"},{"key":"3447_CR79","doi-asserted-by":"crossref","unstructured":"Mediano PAM, Ikkala A, Kievit RA, Jagannathan SR, Varley TF, Stamatakis EA, et al. Fluctuations in Neural Complexity During Wakefulness Relate To Conscious Level and Cognition. bioRxiv: 2021.09.23.461002 [Preprint] 2021 https:\/\/www.biorxiv.org\/content\/10.1101\/2021.09.23.461002v1.","DOI":"10.1101\/2021.09.23.461002"},{"key":"3447_CR80","doi-asserted-by":"publisher","first-page":"106589","DOI":"10.1016\/j.isci.2023.106589","volume":"26","author":"A Ort","year":"2023","unstructured":"Ort A, Smallridge JW, Sarasso S, Casarotto S, von Rotz R, Casanova A, et al. TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology. iScience. 2023;26:106589.","journal-title":"iScience"},{"key":"3447_CR81","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1021\/acschemneuro.3c00289","volume":"15","author":"PAM Mediano","year":"2024","unstructured":"Mediano PAM, Rosas FE, Timmermann C, Roseman L, Nutt DJ, Feilding A, et al. Effects of external stimulation on psychedelic state neurodynamics. ACS Chem Neurosci. 2024;15:462\u201371.","journal-title":"ACS Chem Neurosci"},{"key":"3447_CR82","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1021\/cn500340j","volume":"6","author":"SC Leiser","year":"2015","unstructured":"Leiser SC, Li Y, Pehrson AL, Dale E, Smagin G, Sanchez C. Serotonergic regulation of prefrontal cortical circuitries involved in cognitive processing: a review of individual 5-HT receptor mechanisms and concerted effects of 5-HT receptors exemplified by the multimodal antidepressant vortioxetine. ACS Chem Neurosci. 2015;6:970\u201386.","journal-title":"ACS Chem Neurosci"},{"key":"3447_CR83","doi-asserted-by":"crossref","unstructured":"Juliani A, Chelu V, Graesser L, Safron A A dual-receptor model of serotonergic psychedelics: therapeutic insights from simulated cortical dynamics. bioRxiv: 2024.04.12.589282 [Preprint] 2024 https:\/\/www.biorxiv.org\/content\/10.1101\/2024.04.12.589282v1.","DOI":"10.1101\/2024.04.12.589282"},{"key":"3447_CR84","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00213-018-4872-1","volume":"235","author":"M Tiger","year":"2018","unstructured":"Tiger M, Varn\u00e4s K, Okubo Y, Lundberg J. The 5-HT(1B) receptor - a potential target for antidepressant treatment. Psychopharmacology (Berl). 2018;235:1317\u201334.","journal-title":"Psychopharmacology (Berl)"},{"key":"3447_CR85","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/s41386-022-01369-3","volume":"47","author":"JE Svensson","year":"2022","unstructured":"Svensson JE, Tiger M, Plav\u00e9n-Sigray P, Halldin C, Schain M, Lundberg J. In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study. Neuropsychopharmacology. 2022;47:1863\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"3447_CR86","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0006-8993(01)02823-2","volume":"915","author":"K Varn\u00e4s","year":"2001","unstructured":"Varn\u00e4s K, Hall H, Bonaventure P, Sedvall G. Autoradiographic mapping of 5-HT1B and 5-HT1D receptors in the post mortem human brain using [3H]GR 125743. Brain Res. 2001;915:47\u201357.","journal-title":"Brain Res"},{"key":"3447_CR87","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuint.2013.11.004","volume":"73","author":"S Monta\u00f1ez","year":"2014","unstructured":"Monta\u00f1ez S, Munn JL, Owens WA, Horton RE, Daws LC. 5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice. Neurochem Int. 2014;73:127\u201331.","journal-title":"Neurochem Int"},{"key":"3447_CR88","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00213-012-2797-7","volume":"225","author":"T P\u00e1len\u00ed\u010dek","year":"2013","unstructured":"P\u00e1len\u00ed\u010dek T, Fuj\u00e1kov\u00e1 M, Brunovsk\u00fd M, Hor\u00e1\u010dek J, Gorman I, Bal\u00edkov\u00e1 M, et al. Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology (Berl). 2013;225:75\u201393.","journal-title":"Psychopharmacology (Berl)"},{"key":"3447_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2719","volume":"35","author":"JJ Palamar","year":"2020","unstructured":"Palamar JJ, Acosta P. A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines. Hum Psychopharmacol: Clinical and Experimental. 2020;35:e2719.","journal-title":"Hum Psychopharmacol: Clinical and Experimental"},{"key":"3447_CR90","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.neuron.2022.12.031","volume":"111","author":"C Sayal\u0131","year":"2023","unstructured":"Sayal\u0131 C, Barrett FS. The costs and benefits of psychedelics on cognition and mood. Neuron. 2023;111:614\u201330.","journal-title":"Neuron"},{"key":"3447_CR91","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.tics.2011.08.003","volume":"15","author":"V Menon","year":"2011","unstructured":"Menon V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci. 2011;15:483\u2013506.","journal-title":"Trends Cogn Sci"},{"key":"3447_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29886-1","volume":"13","author":"SL Valk","year":"2022","unstructured":"Valk SL, Xu T, Paquola C, Park B-y, Bethlehem RA, Vos de Wael R, et al. Genetic and phylogenetic uncoupling of structure and function in human transmodal cortex. Nat Commun. 2022;13:2341.","journal-title":"Nat Commun"},{"key":"3447_CR93","doi-asserted-by":"publisher","first-page":"120480","DOI":"10.1016\/j.neuroimage.2023.120480","volume":"285","author":"P Mallaroni","year":"2024","unstructured":"Mallaroni P, Mason NL, Kloft L, Reckweg JT, van Oorsouw K, Toennes SW, et al. Shared functional connectome fingerprints following ritualistic ayahuasca intake. Neuroimage. 2024;285:120480.","journal-title":"Neuroimage"},{"key":"3447_CR94","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1162\/netn_a_00349","volume":"8","author":"HM Tolle","year":"2024","unstructured":"Tolle HM, Farah JC, Mallaroni P, Mason NL, Ramaekers JG, Amico E. The unique neural signature of your trip: Functional connectome fingerprints of subjective psilocybin experience. Netw Neurosci. 2024;8:203\u201325.","journal-title":"Netw Neurosci"},{"key":"3447_CR95","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s41551-024-01242-2","volume":"8","author":"AI Luppi","year":"2024","unstructured":"Luppi AI, Singleton SP, Hansen JY, Jamison KW, Bzdok D, Kuceyeski A, et al. Contributions of network structure, chemoarchitecture and diagnostic categories to transitions between cognitive topographies. Nat Biomed Eng. 2024;8:1142\u201361.","journal-title":"Nat Biomed Eng"},{"key":"3447_CR96","doi-asserted-by":"crossref","unstructured":"Escrichs A, Sanz Perl Y, Fisher PM, Mart\u00ednez-Molina N, G-Guzman E, Frokjaer VG, et al. Whole-brain turbulent dynamics predict responsiveness to pharmacological treatment in major depressive disorder. Mol Psychiatry 2024;30:1069\u201379.","DOI":"10.1038\/s41380-024-02690-7"},{"key":"3447_CR97","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1037\/rev0000455","volume":"131","author":"MK Doss","year":"2024","unstructured":"Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD. Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: A review and reanalysis of acute drug effects on recollection, familiarity, and metamemory. Psychol Rev. 2024;131:523\u201362.","journal-title":"Psychol Rev"},{"key":"3447_CR98","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00259-010-1686-8","volume":"38","author":"A Ettrup","year":"2011","unstructured":"Ettrup A, Hansen M, Santini MA, Paine J, Gillings N, Palner M, et al. Radiosynthesis and in vivo evaluation of a series of substituted 11 C-phenethylamines as 5-HT 2A agonist PET tracers. Eur J Nucl Med Mol Imaging. 2011;38:681\u201393.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3447_CR99","doi-asserted-by":"crossref","unstructured":"Fisher PM, Larsen K, Plav\u00e9n-Sigray P, Knudsen GM, Ozenne B Pitfalls of mapping functional and molecular human brain imaging data from separate cohorts. bioRxiv: 2025.04.22.650037 [Preprint]. 2025 https:\/\/www.biorxiv.org\/content\/10.1101\/2025.04.22.650037v1.","DOI":"10.1101\/2025.04.22.650037"},{"key":"3447_CR100","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41386-022-01361-x","volume":"48","author":"GM Knudsen","year":"2023","unstructured":"Knudsen GM. Sustained effects of single doses of classical psychedelics in humans. Neuropsychopharmacology. 2023;48:145\u201350.","journal-title":"Neuropsychopharmacology"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03447-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03447-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03447-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:04:16Z","timestamp":1779282256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03447-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3447"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03447-0","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.G.R is a scientific consultant to GH Research who have no involvement in the preparation or conception of this manuscript or related data. All other authors have no relevant conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}